MAPT and Hyperglycemia: Hyperglycemia (diabetic pathology) and tau modifications (AD pathology) are tightly correlated and may contribute to the increased incidence of AD, because it has been reported hyperphosphorylated Tau and cleavage in the hippocampus and cortex of type 2 diabetes mice [6].